The TRANSPERS Program on Evidence and Reimbursement for Personalized Medicine is based on a conceptual framework of Stakeholders, Topics, and Mechanisms & Capabilities as shown in the figure.
The program has two components:
- Systematic Evidence Reviews of Payer Coverage Policies: TRANSPERS Payer Coverage Policy Registry contains coverage, reimbursement and policy decisions by payers.
- Understanding Payer Decision-Making: TRANSPERSPayer Advisory Board Program, established in 2007, is comprised of private payers and thought leaders.
In addition, TRANSPERS Director Kathryn Phillips is the chair of the Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (GEECS).
Learn more about our work
Subscribe to our newsletter by emailing [email protected].